JH

James Hardiman

General Partner at DCVC - focused on early stage, applied AI & deep tech investments

San Francisco, California

Invests in

  • Min Investment:

    $5,000,000.00
  • Max Investment:

    $25,000,000.00
  • Target Investment:

    $15,000,000.00

Work Experience

  • Investor and Board Observer

    2017

    Decoding biology to radically improve lives Board Observer 2017 to 2020

2022

  • Investor and Board Director

    2022

    An AI-native biotechnology company harnessing self-supervised learning and human multimodal data for better precision immunotherapies.

  • Investor and Board Observer

    2022

  • Investor and Board Director

    2021

    Developing single cell platforms to unlock a key bottleneck in immunotherapy, enabling curative treatments.

2021

  • Investor and Board Observer

    2021

    Ammonia-to-power for a sustainably-driven future

2020

  • Investor and Board Director

    2020

    The world's first accessible X-Ray CT scanner for engineers

  • Investor and Board Director

    2020

    Transforming how software is built and shipped.

  • Investor and Board Director

    2020

2018

  • Investor and Board Observer

    2018

    Builds infrastructure software to power quantum technology

  • Investor and Board Observer

    2017

    The world’s most extensive agriculture data platform